Marshall Wace North America’s Orthofix Medical OFIX Stock Holding History

Marshall Wace North America’s Portfolio OFIX Stock Details OFIX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-7,141	Closed	-$228K	–	1400
2020 Q2	$228K	Buy	7,141 +6,836	+2,241%	+$227K	﹤0.01%	1055
2020 Q1	$9K	Buy	+305	New	+$11.8K	﹤0.01%	1166
2019 Q2	–	Sell	-435	Closed	-$25K	–	1478
2019 Q1	$25K	Buy	+435	New	+$24.4K	﹤0.01%	1355
2018 Q3	–	Sell	-4,017	Closed	-$228K	–	1239
2018 Q2	$228K	Buy	+4,017	New	+$229K	﹤0.01%	1240
2017 Q3	–	Sell	-33,978	Closed	-$1.56M	–	1439
2017 Q2	$1.56M	Sell	33,978 -17,574	-34%	-$729K	0.01%	812
2017 Q1	$1.96M	Buy	+51,552	New	+$1.91M	0.02%	581

Other funds holding OFIX

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SBH

Segall Bryant & Hamill Chicago, Illinois $8.43B AUM 52.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

PIM

Paradice Investment Management Denver, Colorado $627M AUM 43.41% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Marshall Wace North America's OFIX Position: Q3 2020 in Review

Marshall Wace North America sold out of Orthofix Medical (OFIX) in Q3 2020, closing a stake of 7,141 shares — an estimated $228K sold.

Marshall Wace North America first reported a position in OFIX in Q1 2017 and held it in 6 quarters. The position peaked at $1.96M in Q1 2017. 134 funds tracked by Wall St. Rank hold OFIX as of Q3 2020.

Marshall Wace North America reported no remaining Orthofix Medical position as of Q3 2020 after selling out during the quarter.
Marshall Wace North America sold 7,141 Orthofix Medical shares in Q3 2020, an estimated $228K.
Marshall Wace North America first reported a position in Orthofix Medical in Q1 2017 and held it in 6 quarters.
Marshall Wace North America's Orthofix Medical position peaked at $1.96M in Q1 2017.
134 funds tracked by Wall St. Rank held Orthofix Medical as of Q3 2020.

Based on Marshall Wace North America's 13F filing for Q3 2020, filed 16 Nov 2020.